Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049
Intrinsic Value
Inner Mongolia Furui Medical Science Co., Ltd. engages in the provision of disease diagnosis, drug treatment, and chronic disease management services for liver disease. [ Read More ]
The intrinsic value of one Inner Mongolia Furui Medical Science Co Ltd stock under the Base Case scenario is 27.62 CNY. Compared to the current market price of 46.76 CNY, Inner Mongolia Furui Medical Science Co Ltd is Overvalued by 41%.
Valuation Backtest
Inner Mongolia Furui Medical Science Co Ltd
Run backtest to discover the historical profit from buying and selling Inner Mongolia Furui Medical Science Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Inner Mongolia Furui Medical Science Co Ltd
| Current Assets | 1.3B |
| Cash & Short-Term Investments | 669.1m |
| Receivables | 427.7m |
| Other Current Assets | 187.2m |
| Non-Current Assets | 1.3B |
| Long-Term Investments | 278.4m |
| PP&E | 381.4m |
| Intangibles | 553.2m |
| Other Non-Current Assets | 105.8m |
| Current Liabilities | 251.2m |
| Accounts Payable | 78.8m |
| Accrued Liabilities | 54m |
| Short-Term Debt | 1.2m |
| Other Current Liabilities | 117.3m |
| Non-Current Liabilities | 786.1m |
| Long-Term Debt | 40.1m |
| Other Non-Current Liabilities | 746.1m |
Earnings Waterfall
Inner Mongolia Furui Medical Science Co Ltd
|
Revenue
|
1B
CNY
|
|
Cost of Revenue
|
-269.9m
CNY
|
|
Gross Profit
|
771.8m
CNY
|
|
Operating Expenses
|
-556.2m
CNY
|
|
Operating Income
|
215.6m
CNY
|
|
Other Expenses
|
-113.3m
CNY
|
|
Net Income
|
102.2m
CNY
|
Free Cash Flow Analysis
Inner Mongolia Furui Medical Science Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Inner Mongolia Furui Medical Science Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Inner Mongolia Furui Medical Science Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Inner Mongolia Furui Medical Science Co Ltd's solvency score is 84/100. The higher the solvency score, the more solvent the company is.
Score
Inner Mongolia Furui Medical Science Co Ltd's solvency score is 84/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Inner Mongolia Furui Medical Science Co Ltd
According to Wall Street analysts, the average 1-year price target for Inner Mongolia Furui Medical Science Co Ltd is 25.22 CNY .
Shareholder Return
Price
Inner Mongolia Furui Medical Science Co Ltd
| Average Annual Return | 28.8% |
| Standard Deviation of Annual Returns | 53.66% |
| Max Drawdown | -44% |
| Market Capitalization | 12.3B CNY |
| Shares Outstanding | 256 343 100 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Inner Mongolia Furui Medical Science Co., Ltd. engages in the provision of disease diagnosis, drug treatment, and chronic disease management services for liver disease. The company is headquartered in Beijing, Beijing and currently employs 645 full-time employees. The company went IPO on 2010-01-20. The firm is mainly engaged in the manufacture and sale of medicines, the research, development and sale of diagnostic equipment, as well as the provision of related services. The Company’s main products include Fufang Biejia Ruangan talbets, Kezhi capsules and instantaneous elastic imaging equipment FibroScan. The firm distributes its products in domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Inner Mongolia Furui Medical Science Co Ltd stock under the Base Case scenario is 27.62 CNY.
Compared to the current market price of 46.76 CNY, Inner Mongolia Furui Medical Science Co Ltd is Overvalued by 41%.
You don't have any saved screeners yet
